# Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/serum-levels-of-il-6-and-il-1-can-predict-the-efficacy-of-gemcitabine-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shuichi Mitsunaga,Masafumi Ikeda,Satoshi Shimizu,Izumi Ohno,J. Furuse,Masatoshi Inagaki,Sayumi Higashi,Hiroyuki Kato,Keiji Terao,Atsushi Ochiai |
| Citations | 154 |
| DOI | 10.1038/bjc.2013.174 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/bjc2013174.pdf |
| OpenAlex ID | https://openalex.org/W2087075862 |
| PMID | 23591198 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Izumi Ohno](https://scholariq.org/researchers/izumi-ohno/)

## Paper journal

- [British Journal of Cancer](https://scholariq.org/journals/british-journal-of-cancer/)

## Paper primary topic

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Paper topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Chemokine receptors and signaling](https://scholariq.org/topics/chemokine-receptors-and-signaling/)
- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.